C4 Therapeutics, Inc. (CCCC)
C4 Therapeutics, Inc. (CCCC)
| Financial Ratios | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Return on Equity | -10.886 | -7.998 | -20.756 | -14.99 |
| Net Profit Margin | -414.516 | -186.302 | -285.387 | -403.729 |
| Debt to Asset Ratio | 28.77 | 28.542 | 41.84 | 41.299 |
| Cash Ratio | 224.867 | 225.851 | 163.608 | 175.808 |
| Quick Ratio | 900.477 | 781.394 | 575.501 | 505.509 |
| Current Ratio | 900.477 | 781.394 | 575.501 | 505.509 |